Lupus Erythematosus News and Research

RSS
EULAR releases new recommendations for non-pharmacological management of SLE and SSc

EULAR releases new recommendations for non-pharmacological management of SLE and SSc

Study shows that anti-PTM antibodies are often present in autoimmune mediated liver disease

Study shows that anti-PTM antibodies are often present in autoimmune mediated liver disease

Study finds that patients with systemic autoimmune rheumatic diseases had a lower antibody response than healthy controls after Omicron infection

Study finds that patients with systemic autoimmune rheumatic diseases had a lower antibody response than healthy controls after Omicron infection

2023 recipients of the Diversity in Lupus Research Awards announced

2023 recipients of the Diversity in Lupus Research Awards announced

Older age and certain health conditions increase risk of COVID-19 death in boosted individuals

Older age and certain health conditions increase risk of COVID-19 death in boosted individuals

Measurable upticks in gut bacteria blooms tied to lupus flare-ups

Measurable upticks in gut bacteria blooms tied to lupus flare-ups

Unlocking the secret to lifelong health: the power of optimal immune resilience

Unlocking the secret to lifelong health: the power of optimal immune resilience

Estimate of treatment effect modification by comorbidity using participant data

Estimate of treatment effect modification by comorbidity using participant data

Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis

Lupus Therapeutics announces three Phase 3 clinical trials testing new therapies for SLE and lupus nephritis

Study finds improved survival in patients with SLE-associated PAH

Study finds improved survival in patients with SLE-associated PAH

Long-term side effects of modern treatment for rheumatoid arthritis

Long-term side effects of modern treatment for rheumatoid arthritis

Rheumatic and musculoskeletal diseases increase the risk of lethal comorbidities

Rheumatic and musculoskeletal diseases increase the risk of lethal comorbidities

Burden of autoimmune disease continues to increase over time, research suggests

Burden of autoimmune disease continues to increase over time, research suggests

Common diabetes drug could be repurposed as a treatment for autoimmune disorders

Common diabetes drug could be repurposed as a treatment for autoimmune disorders

Lupus Landmark Study launched to accelerate the development of personalized treatments for lupus patients

Lupus Landmark Study launched to accelerate the development of personalized treatments for lupus patients

Long-term opioid use more common among patients with rheumatic and musculoskeletal conditions

Long-term opioid use more common among patients with rheumatic and musculoskeletal conditions

UT Southwestern expert says common skin problems could signal a more serious rheumatic disease

UT Southwestern expert says common skin problems could signal a more serious rheumatic disease

First-in-human clinical study begins investigating the duoCAR T-cell therapy for treatment of HIV

First-in-human clinical study begins investigating the duoCAR T-cell therapy for treatment of HIV

Is there an association between COVID-19 and the risk of developing an autoimmune disease?

Is there an association between COVID-19 and the risk of developing an autoimmune disease?

How do viral infections cause autoimmune diseases?

How do viral infections cause autoimmune diseases?

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.